Skip to main content

and
  1. Article

    Open Access

    Author Correction: Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Meng Shen, Meng-Yao Wu, Long-Pei Chen, Qiaoming Zhi, Fei-Ran Gong in Scientific Reports (2021)

  2. Article

    Open Access

    Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA

    Cantharidin is an active constituent of mylabris, a traditional Chinese medicine and is a potent and selective inhibitor of protein phosphatase 2A (PP2A) that plays an important role in cell cycle control, apo...

    Meng Shen, Meng-Yao Wu, Long-Pei Chen, Qiaoming Zhi, Fei-Ran Gong in Scientific Reports (2015)

  3. Article

    Open Access

    Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study

    Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Current therapies are insufficient, making HCC an intractable disease. Our previous studies confirmed that inhibi...

    Wei Li, Dao-Ming Li, Kai Chen, Zheng Chen, Yang Zong, Hong Yin, Ze-Kuan Xu in BMC Cancer (2012)